Results 11 to 20 of about 31,195 (193)

Five-Years Tigecycline Experience an Analysis of Real-Life Data [PDF]

open access: yesHaseki Tıp Bülteni, 2018
Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia.
Fatih Temocin   +8 more
doaj   +2 more sources

Resistance mechanisms of tigecycline in Acinetobacter baumannii [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a common pathogen causing various infectious diseases. Currently, the drug resistance rate of A.
Chunli Sun   +7 more
doaj   +2 more sources

Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.

open access: yesPLoS ONE, 2015
KPC-producing Klebsiella pneumoniae isolates have emerged as important pathogens of nosocomial infections, and tigecycline is one of the antibiotics recommended for severe infections caused by KPC-producing K. pneumoniae.
Fang He   +6 more
doaj   +2 more sources

Isoniazid potentiates tigecycline to kill methicillin-resistant Staphylococcus aureus

open access: yesEmerging Microbes and Infections
Therapeutic option for treating methicillin-resistant Staphylococcus aureus (MRSA) infection is urgently required since its resistance to a broad spectrum of currently available antibiotics.
Xuan-wei Chen   +6 more
doaj   +2 more sources

Comparative Genomic Analysis of Tigecycline Resistance Development in Clinical Acinetobacter baumannii Isolates [PDF]

open access: yesInfection and Drug Resistance
Xiaoxia Li,1,* Junnian Liu,2,* Xinyu Zhang,1 Juan Li,3 Luhan Xuan,1 Sue Yuan,1 Jianglin Li,1 Yu Sun,1 Xuefei Du1 1Clinical Laboratory, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People’s Republic of
Li X   +8 more
doaj   +1 more source

Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline

open access: yesNature Communications
Tigecycline is widely used for treating complicated bacterial infections for which there are no effective drugs. It inhibits bacterial protein translation by blocking the ribosomal A-site.
Xiang Li   +6 more
doaj   +2 more sources

In-Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against Carbapenem-Resistant Gram-Negative Isolates at a Tertiary Care Hospital in Lahore, Pakistan: A Cross-Sectional Study. [PDF]

open access: yesMicrobiologyopen
Of 210 consecutive non‐duplicate carbapenem‐resistant Gram‐negative isolates collected at a tertiary care hospital in Lahore, Pakistan (December 2024–May 2025), 200 had a ceftazidime‐avibactam (CAZ–AVI) result; 70.5% were susceptible (141/200; 95% CI 63.7–76.7). Susceptibility varied by sample source (p = 0.008), being highest in blood cultures (81.2%),
Yunus F   +5 more
europepmc   +2 more sources

Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus

open access: yesMicrobiology Spectrum, 2023
Tigecycline is an important antibacterial drug for treating infection by clinical multidrug-resistant bacteria, and tigecycline-resistant Staphylococcus aureus (TRSA) has been increasingly reported in recent years.
Honghao Huang   +6 more
doaj   +1 more source

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
The increasing incidence of tigecycline resistance undoubtedly constitutes a serious threat to global public health. The combination therapies had become the indispensable strategy against this threat. Herein, 11 clinical tigecycline-resistant Klebsiella
Lilan Sun   +7 more
doaj   +1 more source

Proteomics Study of the Synergistic Killing of Tigecycline in Combination With Aminoglycosides Against Carbapenem-Resistant Klebsiella pneumoniae

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Co-administration of antibiotics with synergistic effects is one method to combat carbapenem-resistant organisms. Although the synergistic effects of tigecycline combined with aminoglycosides against carbapenem-resistant Klebsiella pneumoniae (CRKP) have
Xinqian Ma   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy